Top compounds associated with response to EGR1


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.018 0.6
mRNA BRD-K34099515 CTRPv2 pan-cancer AAC -0.038 0.6
mRNA Sildenafil CTRPv2 pan-cancer AAC -0.02 0.6
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.019 0.6
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.018 0.6
mRNA CGP-60474 GDSC1000 pan-cancer AAC -0.028 0.6
mRNA AT13387 CTRPv2 pan-cancer AAC 0.024 0.6
mRNA BRD-A02303741:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.019 0.6
mRNA PD173074 GDSC1000 pan-cancer AAC -0.019 0.6
mRNA cabozantinib CTRPv2 pan-cancer AAC 0.018 0.6
Download CSV